We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+3.83%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$5.56B
AUM Growth
+$273M
Cap. Flow
+$119M
Cap. Flow %
2.13%
Top 10 Hldgs %
28.06%
Holding
379
New
20
Increased
141
Reduced
127
Closed
12

Top Buys

Rank Stock Value
1
CFR icon
Cullen/Frost Bankers
CFR
+$52.6M
2
LMT icon
Lockheed Martin
LMT
+$50.9M
3
SE
Spectra Energy Corp Wi
SE
+$38M
4
PAYX icon
Paychex
PAYX
+$27.7M
5
AAPL icon
Apple
AAPL
+$24.8M

Top Sells

Rank Stock Value
1
BNS icon
Scotiabank
BNS
+$37.7M
2
RTX icon
RTX Corp
RTX
+$32.6M
3
KMI icon
Kinder Morgan
KMI
+$30.9M
4
DLR icon
Digital Realty Trust
DLR
+$27.6M
5
NNN icon
NNN REIT
NNN
+$26.4M

Sector Composition

Rank Sector Weight
1 Technology 15.97%
2 Consumer Staples 15.67%
3 Healthcare 14.85%
4 Energy 12.26%
5 Industrials 11.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYY icon
126
Sysco
SYY
$39.6B
$3.24M 0.06%
101,811
-40,837
-29% -$1.37M
KDP icon
127
Keurig Dr Pepper
KDP
$42.3B
$3.24M 0.06%
72,260
-358,364
-83% -$16.5M
BRK.A icon
128
Berkshire Hathaway Class A
BRK.A
$1.11T
$3.24M 0.06%
19
EPP icon
129
iShares MSCI Pacific ex Japan ETF
EPP
$2.26B
$3.2M 0.06%
67,168
-941
-1% -$42.9K
PDCO
130
DELISTED
Patterson Companies, Inc.
PDCO
$3.11M 0.06%
77,372
+55
+0.1% +$2.23K
ORCL icon
131
Oracle
ORCL
$420B
$3.05M 0.05%
92,038
-567
-0.6% -$18.4K
LLY icon
132
Eli Lilly
LLY
$995B
$2.98M 0.05%
59,284
+29
+0% +$1.52K
HUB.B
133
DELISTED
HUBBELL INC CL-B
HUB.B
$2.94M 0.05%
28,040
CHRW icon
134
C.H. Robinson
CHRW
$18.1B
$2.85M 0.05%
47,855
-27,953
-37% -$1.64M
SAP icon
135
SAP
SAP
$226B
$2.81M 0.05%
38,054
-18
-0% -$1.33K
PSX icon
136
Phillips 66
PSX
$82.5B
$2.75M 0.05%
47,620
-1,628
-3% -$94.4K
CLX icon
137
Clorox
CLX
$12.7B
$2.73M 0.05%
33,380
+400
+1% +$33.8K
XLK icon
138
State Street Technology Select Sector SPDR ETF
XLK
$123B
$2.63M 0.05%
164,060
+4,100
+3% +$65.4K
PFE icon
139
Pfizer
PFE
$145B
$2.53M 0.05%
92,868
-5,525
-6% -$150K
COHR icon
140
Coherent
COHR
$63.3B
$2.52M 0.05%
134,285
+14,140
+12% +$263K
MON
141
DELISTED
Monsanto Co
MON
$2.44M 0.04%
23,368
-750
-3% -$75.4K
PSMT icon
142
Pricesmart
PSMT
$5.97B
$2.43M 0.04%
25,545
+510
+2% +$45.8K
CAT icon
143
Caterpillar
CAT
$404B
$2.43M 0.04%
29,164
-42
-0.1% -$3.55K
OII icon
144
Oceaneering
OII
$5.02B
$2.43M 0.04%
29,860
+610
+2% +$49K
STE icon
145
Steris
STE
$22.7B
$2.41M 0.04%
56,114
+1,505
+3% +$65.4K
CL icon
146
Colgate-Palmolive
CL
$73.8B
$2.38M 0.04%
40,194
+6,400
+19% +$379K
PNY
147
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
$2.34M 0.04%
71,140
CRR
148
DELISTED
Carbo Ceramics Inc.
CRR
$2.31M 0.04%
23,330
-8,215
-26% -$698K
HDV
149
iShares Core High Dividend ETF
HDV
$14.8B
$2.29M 0.04%
+172,920
New +$2.34M
CTAS icon
150
Cintas
CTAS
$81.5B
$2.26M 0.04%
176,452
-1,776
-1% -$21.5K

Similar funds

Bahl & Gaynor's Q3 2013 Portfolio in Review

As of Q3 2013, Bahl & Gaynor held 379 positions worth $5.56B, up 5.2% from $5.29B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Bahl & Gaynor's Q3 2013 filing shows 20 new, 141 increased, 127 reduced and 12 closed positions. Its largest new stake was iShares Core High Dividend ETF: 172,920 shares worth $2.29M. The largest sale was Scotiabank, an estimated $37.7M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Bahl & Gaynor's largest Q3 2013 buy was iShares Core High Dividend ETF: 172,920 shares worth $2.29M.
  • Bahl & Gaynor added most to Cullen/Frost Bankers in Q3 2013, an estimated $52.6M increase.
  • Bahl & Gaynor's biggest Q3 2013 reduction was Scotiabank, cutting an estimated $37.7M.
  • Bahl & Gaynor fully exited SM Energy in Q3 2013, selling an estimated $539K.
  • Bahl & Gaynor's ten largest holdings make up 28% of its $5.56B portfolio in Q3 2013.
  • Bahl & Gaynor opened 20 new positions and closed 12 in Q3 2013.
  • Bahl & Gaynor's portfolio value rose 5.2% quarter-over-quarter to $5.56B.

Based on Bahl & Gaynor's 13F filing for Q3 2013, filed 13 Nov 2013.